Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000053

Director sold 786 shares at an average $20.92 ($16,439)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Pauls Matthew · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-02 Sale : show line 1 in the form 10b5-1 −415 $20.52 $8,514 15,521 D
2026-04-02 Sale : show line 2 in the form 10b5-1 −371 $21.36 $7,926 15,150 D
Open-market sales · 786 sh · avg $20.92 · $16,439
Loading xslF345X06/wk-form4_1775509361.xml…